Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis.
The Journal of dermatological treatment
View this publicationThe Journal of dermatological treatment
View this publicationJournal of immunology (Baltimore, Md. : 1950)
View this publicationInfection
View this publicationbioRxiv : the preprint server for biology
View this publicationeLife
View this publicationClinical research in cardiology : official journal of the German Cardiac Society
View this publicationJournal of thrombosis and haemostasis : JTH
View this publicationThe Journal of biological chemistry
View this publicationMolecular therapy. Nucleic acids
View this publicationFrontiers in genetics
View this publication